What is the price-to-earnings ratio of cbdMD?
The price-earnings ratio of cbdMD is currently 0.07.
cbdMD P/S 2024
cbdMD P/S
0.07
Ticker
YCBD
ISIN
US12482W1018
WKN
A2PJM3
As of Sep 10, 2024, cbdMD's P/S ratio stood at 0.07, a -56.25% change from the 0.16 P/S ratio recorded in the previous year.
The cbdMD P/S history
cbdMD Aktienanalyse
What does cbdMD do?
CBDMD Inc. was founded in 2015 and is based in Charlotte, North Carolina. It is a leading company in the manufacturing and marketing of high-quality CBD products, and has quickly gained recognition and a strong reputation in the industry. The company's business model is centered around a clear mission: to offer high-quality CBD solutions that improve people's lives. cbdMD Inc. not only strives to produce products of the highest quality, but also aims to spread information about the benefits of CBD. The goal is to raise awareness among people that CBD is a natural way to alleviate stress, anxiety, pain, and other ailments. The company offers a wide range of CBD products, including oils, tinctures, capsules, gummies, topicals, bath additives, pet products, and more. cbdMD Inc. manufactures its products from pure natural ingredients and they are THC-free, meaning they have no psychoactive effects. The company operates in various sectors, including the sports segment, where it focuses on meeting the needs of athletes. cbdMD Inc. is dedicated to developing products that promote muscle recovery, alleviate pain, and improve focus. In the pet treatments segment, cbdMD Inc. offers a wide range of products specially tailored for the needs of pets. The products range from CBD oils and treats to bath balms and creams. The company places special emphasis on quality to ensure that it is also a gentle treatment method. cbdMD Inc. has placed its products in retail stores such as CVS and CBD Shops, and also collaborates with other online platforms. However, the core business of cbdMD Inc. is the manufacturing and sale of CBD oils. These oils are available in different sizes and concentrations. The oil blends, which are primarily plant-based, are gluten-free and sugar-free. They are rich in cannabinoids, contain hemp oil with omega-3, -6, and -9 fatty acids, and thus offer valuable health and wellness as a dietary supplement. In conclusion, cbdMD Inc. has a clear vision of producing high-quality products and spreading information about the benefits of CBD. With its wide range of CBD products and consistent focus on customer needs, the company has quickly gained recognition in the industry. Through an environmentally responsible value chain and transparent communication with its customers, cbdMD Inc. promotes awareness of natural dietary supplements and health care. cbdMD ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding cbdMD's P/S Ratio
cbdMD's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing cbdMD's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating cbdMD's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in cbdMD’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about cbdMD stock
How has the price-earnings ratio of cbdMD changed compared to last year?
The price-to-earnings ratio of cbdMD has increased by -56.25% fallen (meaning "decreased" or "dropped") compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of cbdMD high compared to other companies?
Yes, the price-to-earnings ratio of cbdMD is high compared to other companies.
How does an increase in the price-earnings ratio of cbdMD affect the company?
An increase in the price-earnings ratio of cbdMD would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of cbdMD affect the company?
A decrease in the price-earnings ratio of cbdMD would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of cbdMD?
Some factors that influence the price-earnings ratio of cbdMD are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does cbdMD pay?
Over the past 12 months, cbdMD paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, cbdMD is expected to pay a dividend of 0 USD.
What is the dividend yield of cbdMD?
The current dividend yield of cbdMD is .
When does cbdMD pay dividends?
cbdMD pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of cbdMD?
cbdMD paid dividends every year for the past 0 years.
What is the dividend of cbdMD?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is cbdMD located?
cbdMD is assigned to the 'Health' sector.
Wann musste ich die Aktien von cbdMD kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of cbdMD from 9/10/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/10/2024.
When did cbdMD pay the last dividend?
The last dividend was paid out on 9/10/2024.
What was the dividend of cbdMD in the year 2023?
In the year 2023, cbdMD distributed 0 USD as dividends.
In which currency does cbdMD pay out the dividend?
The dividends of cbdMD are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von cbdMD
Our stock analysis for cbdMD Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of cbdMD Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
